Clinical Trial Details
| Trial ID: | L1325 |
| Source ID: | NCT03311581 |
| Associated Drug: | Propofol |
| Title: | The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | End Stage Renal Disease|Hemodialysis Complication |
| Interventions: | DRUG: Propofol|DEVICE: Sevoflurane |
| Outcome Measures: | Primary: Change in blood pressure, Systolic blood pressure, diastolic blood pressure, The blood pressure change between baseline, post-induction 3mins, operation start, post-operation 10 mins,post-operation 30 mins,post-operation 1 hour,post-operation 2 hours, end of surgery, recovery room, up to 4 hours | Secondary: analgesics dosage, post-operation analgesics dosage, The amount of analgesics dosage use at recovery room,an average of 4 hours|Change in pain intensity, Visual Analog Score for pain, The pain intensity change at recovery room, post-operation day 1, post-operation day 2 |
| Sponsor/Collaborators: | Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 47 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT |
| Start Date: | 2017-09-11 |
| Completion Date: | 2021-06-04 |
| Results First Posted: | |
| Last Update Posted: | 2021-09-05 |
| Locations: | Kaohsiung Medical University Hospital, Kaohsiung, 807, Taiwan |
| URL: | https://clinicaltrials.gov/show/NCT03311581 |
